Testing GMDTC for removing excess cadmium
This trial tests an injectable medicine called GMDTC to help remove extra cadmium (a heavy metal) from the body. It is for people with high cadmium levels and decent kidney function, to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- Your urine shows high cadmium levels (more than 5 micrograms for every gram of creatinine).
- Your kidneys work well enough (eGFR 30 or higher on a blood test).
- You do not have poorly controlled diabetes or a serious heart rhythm problem.
- You are not on dialysis and have no known allergies to the study drug ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection called GMDTC to see if it can protect the kidneys in people who already have mild kidney problems from cisplatin chemotherapy and need more cisplatin. It aims to reduce further kidney damage while continuing cancer treatment.
This study tests how a new drug, golcadomide, works in people with severe kidney problems compared to those with normal kidneys. It helps see if the drug needs different dosing for patients with kidney issues.
This study tests a treatment that removes lead from the blood to see if it can help slow down kidney damage in people with type 2 diabetes. It may be an option for those with higher lead levels and early-stage kidney disease.
This study tests whether a team of doctors and nurses working together can improve heart and kidney health in people with type 2 diabetes and chronic kidney disease. The team will coordinate care for blood sugar, blood pressure, and kidney function.
This trial tests whether a medication that removes lead from the body can slow the worsening of kidney function in people with type 2 diabetes and kidney disease. It might help if you have higher lead levels in your blood.
This research study tests an experimental treatment for people with chronic kidney disease who are not yet on dialysis. The goal is to see if the treatment is safe and how it affects kidney function.
Hear when a new Cadmium Exceeds the Standard trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.